Exact Mass: 374.18416260000004
Exact Mass Matches: 374.18416260000004
Found 361 metabolites which its exact mass value is equals to given mass value 374.18416260000004
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Hydroxyzine
A histamine H1 receptor antagonist that is effective in the treatment of chronic urticaria, dermatitis, and histamine-mediated pruritus. Unlike its major metabolite cetirizine, it does cause drowsiness. It is also effective as an antiemetic, for relief of anxiety and tension, and as a sedative. [PubChem] CONFIDENCE standard compound; INTERNAL_ID 1306; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8146; ORIGINAL_PRECURSOR_SCAN_NO 8142 CONFIDENCE standard compound; INTERNAL_ID 1306; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8167; ORIGINAL_PRECURSOR_SCAN_NO 8166 CONFIDENCE standard compound; INTERNAL_ID 1306; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8152; ORIGINAL_PRECURSOR_SCAN_NO 8147 CONFIDENCE standard compound; INTERNAL_ID 1306; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8169; ORIGINAL_PRECURSOR_SCAN_NO 8167 CONFIDENCE standard compound; INTERNAL_ID 1306; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8128; ORIGINAL_PRECURSOR_SCAN_NO 8124 CONFIDENCE standard compound; INTERNAL_ID 1306; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8120; ORIGINAL_PRECURSOR_SCAN_NO 8118 N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BB - Diphenylmethane derivatives D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D003879 - Dermatologic Agents > D000982 - Antipruritics Hydroxyzine, a benzodiazepine antihistamine agent, acts as an orally active histamine?H1-receptor and serotonin antagonist. Hydroxyzine has anxiolytic effect and can be used for the research of generalised anxiety disorder[1].
Adarotene
C274 - Antineoplastic Agent > C2122 - Cell Differentiating Agent > C1934 - Differentiation Inducer C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C804 - Retinoic Acid Agent C308 - Immunotherapeutic Agent > C129820 - Antineoplastic Immunomodulating Agent D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids
6-Epi-7-isocucurbic acid glucoside
6-Epi-7-isocucurbic acid glucoside is found in fats and oils. 6-Epi-7-isocucurbic acid glucoside is a constituent of Perilla frutescens (perilla) Constituent of Perilla frutescens (perilla). 6-Epi-7-isocucurbic acid glucoside is found in fats and oils and herbs and spices.
10,13-Dimethyl-7-sulfanylspiro[2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17,5'-oxolane]-2',3-dione
Spinochalcone B
1-(3-fluoropentyl)-N-(naphthalen-1-yl)-1H-indole-3-carboxamide
C24H23FN2O (374.17943199999996)
1-(2-fluoropentyl)-N-(naphthalen-1-yl)-1H-indole-3-carboxamide
C24H23FN2O (374.17943199999996)
2,6-dimethyl-3-hydroxymethyl-6-hydroxy-1,4-heptadiene-9-O-(6-acetyl-beta-D-glucopyranoside)
7-Methyl-3-methylene-6E-octen-1,8-diol-1-O-beta-D-(2-O-acetylglucopyranoside)|7-Methyl-3-methylene-6E-octen-1,8-diol-1-O-beta-D-<2-O-acetylglucopyranoside>|8-O-(2-Acetyl-beta-D-glucopyranoside)-(E)-2-Methyl-6-methylene-2-octene-1,8-diol
(1R,2R)-p-menth-4(5)-ene-1,2-diol 1-O-(6-O-acetyl-beta-D-glucopyranoside)
9-hydroxy-gamma-geraniol-1-O-(6-acetyl-beta-D-glucopyranoside)
(1R,2R)-p-menth-4(5)-ene-1,2-diol 1-O-(2-O-acetyl-beta-D-glucopyranoside)|(1R,2R)-p-Menth-4(5)-ene-1,2-diol 1-O-??-D-(2-O-acetyl)glucopyranoside
C18H30O8_Cyclopentaneacetic acid, 3-(hexopyranosyloxy)-2-[(2Z)-2-penten-1-yl]
2-[2-[(Z)-pent-2-enyl]-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycyclopentyl]acetic acid
hydroxyzine
N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BB - Diphenylmethane derivatives D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D003879 - Dermatologic Agents > D000982 - Antipruritics Hydroxyzine, a benzodiazepine antihistamine agent, acts as an orally active histamine?H1-receptor and serotonin antagonist. Hydroxyzine has anxiolytic effect and can be used for the research of generalised anxiety disorder[1].
2-[2-[(Z)-pent-2-enyl]-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycyclopentyl]acetic acid_major
Ala Ala Asp Val
Ala Ala Val Asp
Ala Asp Ala Val
Ala Asp Gly Ile
Ala Asp Gly Leu
Ala Asp Ile Gly
Ala Asp Leu Gly
Ala Asp Val Ala
Ala Glu Gly Val
Ala Glu Val Gly
Ala Gly Asp Ile
Ala Gly Asp Leu
Ala Gly Glu Val
Ala Gly Ile Asp
Ala Gly Leu Asp
Ala Gly Val Glu
Ala Ile Asp Gly
Ala Ile Gly Asp
Ala Leu Asp Gly
Ala Leu Gly Asp
Ala Pro Ser Thr
Ala Pro Thr Ser
Ala Ser Pro Thr
Ala Ser Thr Pro
Ala Thr Pro Ser
Ala Thr Ser Pro
Ala Val Ala Asp
Ala Val Asp Ala
Ala Val Glu Gly
Ala Val Gly Glu
Asp Ala Ala Val
Asp Ala Gly Ile
Asp Ala Gly Leu
Asp Ala Ile Gly
Asp Ala Leu Gly
Asp Ala Val Ala
Asp Gly Ala Ile
Asp Gly Ala Leu
Asp Gly Ile Ala
Asp Gly Leu Ala
Asp Ile Ala Gly
Asp Ile Gly Ala
Asp Leu Ala Gly
Asp Leu Gly Ala
Asp Val Ala Ala
Glu Ala Gly Val
Glu Ala Val Gly
Glu Gly Ala Val
Glu Gly Gly Ile
Glu Gly Gly Leu
Glu Gly Ile Gly
Glu Gly Leu Gly
Glu Gly Val Ala
Glu Ile Gly Gly
Glu Leu Gly Gly
Glu Val Ala Gly
Glu Val Gly Ala
Gly Ala Asp Ile
Gly Ala Asp Leu
Gly Ala Glu Val
Gly Ala Ile Asp
Gly Ala Leu Asp
Gly Ala Val Glu
Gly Asp Ala Ile
Gly Asp Ala Leu
Gly Asp Ile Ala
Gly Asp Leu Ala
Gly Glu Ala Val
Gly Glu Gly Ile
Gly Glu Gly Leu
Gly Glu Ile Gly
Gly Glu Leu Gly
Gly Glu Val Ala
Gly Gly Glu Ile
Gly Gly Glu Leu
Gly Gly Ile Glu
Gly Gly Lys Asn
Gly Gly Leu Glu
Gly Gly Asn Lys
Gly Ile Ala Asp
Gly Ile Asp Ala
Gly Ile Glu Gly
Gly Ile Gly Glu
Gly Lys Gly Asn
Gly Lys Asn Gly
Gly Leu Ala Asp
Gly Leu Asp Ala
Gly Leu Glu Gly
Gly Leu Gly Glu
Gly Asn Gly Lys
Gly Asn Lys Gly
Gly Pro Thr Thr
Gly Thr Pro Thr
Gly Thr Thr Pro
Gly Val Ala Glu
Gly Val Glu Ala
Ile Ala Asp Gly
Ile Ala Gly Asp
Ile Asp Ala Gly
Ile Asp Gly Ala
Ile Glu Gly Gly
Ile Gly Ala Asp
Ile Gly Asp Ala
Ile Gly Glu Gly
Ile Gly Gly Glu
Lys Gly Gly Asn
Lys Gly Asn Gly
Lys Asn Gly Gly
Leu Ala Asp Gly
Leu Ala Gly Asp
Leu Asp Ala Gly
Leu Asp Gly Ala
Leu Glu Gly Gly
Leu Gly Ala Asp
Leu Gly Asp Ala
Leu Gly Glu Gly
Leu Gly Gly Glu
Asn Gly Gly Lys
Asn Gly Lys Gly
Asn Lys Gly Gly
Pro Ala Ser Thr
Pro Ala Thr Ser
Pro Gly Thr Thr
Pro Ser Ala Thr
Pro Ser Thr Ala
Pro Thr Ala Ser
Pro Thr Gly Thr
Pro Thr Ser Ala
Pro Thr Thr Gly
Ser Ala Pro Thr
Ser Ala Thr Pro
Ser Pro Ala Thr
Ser Pro Thr Ala
Ser Thr Ala Pro
Ser Thr Pro Ala
Thr Ala Pro Ser
Thr Ala Ser Pro
Thr Gly Pro Thr
Thr Gly Thr Pro
Thr Pro Ala Ser
Thr Pro Gly Thr
Thr Pro Ser Ala
Thr Pro Thr Gly
Thr Ser Ala Pro
Thr Ser Pro Ala
Thr Thr Gly Pro
Thr Thr Pro Gly
Val Ala Ala Asp
Val Ala Asp Ala
Val Ala Glu Gly
Val Ala Gly Glu
Val Asp Ala Ala
Val Glu Ala Gly
Val Glu Gly Ala
Val Gly Ala Glu
Val Gly Glu Ala
6-Epi-7-isocucurbic acid glucoside
METHYL 6-(1-BOC-PIPERIDIN-4-YLOXY)INDOLE-2-CARBOXYLATE
C20H26N2O5 (374.18416260000004)
1,6-HEXANEDIYLBIS[OXY(2-HYDROXY-3,1-PROPANEDIYL)] BISACRYLATE
3-(N-Styrylmethyl-2-aminoethylamino)propyltrimethoxysilane hydrochloride
Glasdegib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01X - Other antineoplastic agents > L01XJ - Hedgehog pathway inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C188731 - Hedgehog Pathway Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor
6-ACETYLAMINO-4-OXO-2-SPIRO(N-BOC-PIPERIDINE-4-YL)-BENZOPYRAN
C20H26N2O5 (374.18416260000004)
1-BOC-4-(BENZOFURAN-2-YL-CARBOXY-METHYL)-[1,4]DIAZEPANE
C20H26N2O5 (374.18416260000004)
1H-Benzimidazole-1-acetamide,N-(1-methylethyl)-2-[[2-oxo-2-(1-piperidinyl)ethyl]thio]-(9CI)
4-[2-(Ethoxycarbonyl)-5-benzofuranyl]-1-piperazinecarboxylic acid tert-butyl ester
C20H26N2O5 (374.18416260000004)
1,2-Ethanediamine, N-3-(trimethoxysilyl)propyl-, N-(ethenylphenyl)methyl derivs., hydrochlorides
Isopropyl (2S)-7-Cyano-4-(pyridin-2-ylmethyl)-1,2,3,4-tetrahydrocyclopenta[b]indol-2-ylcarbamate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen
Pyrimidine-4,6-dicarboxylic acid bis-(3-methyl-benzylamide)
2-amino-5-[3-(1-ethyl-1H-pyrazol-5-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-N,N-dimethylbenzamide
N-(1-ethyl-6-methyl-3-pyrazolo[3,4-b]quinolinyl)-2-(4-methoxyphenyl)acetamide
n-[[2-Methyl-4-hydroxycarbamoyl]but-4-yl-n]-benzyl-p-[phenyl]-p-[methyl]phosphinamid
Glycyl-L-alpha-amino-epsilon-pimelyl-D-alanyl-D-alanine
2-[2-Pent-2-enyl-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycyclopentyl]acetic acid
benzoic acid [(13S)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] ester
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Leu-Asp-Gln
A tripeptide composed of L-leucine, L-aspartic acid and L-glutamine joined in sequence by peptide linkages.
Ala-Leu-Asp-Gly
A tetrapeptide composed of L-alanine, L-leucine, L-aspartic acid and glycine joined in sequence by peptide linkages.
N-{3-[2-(1-azepanyl)-4,5-dicyanophenoxy]phenyl}acetamide
N-(2-furanylmethyl)-5,7-dimethyl-6-[(3-methylphenyl)methyl]-3-pyrazolo[1,5-a]pyrimidinecarboxamide
N-cyclohexyl-2-[[5-[(4-methoxyphenyl)methyl]-4-methyl-1,2,4-triazol-3-yl]thio]acetamide
4-(4-hydroxy-3-methoxyphenyl)-6-methyl-2-oxo-3,4-dihydro-1H-pyrimidine-5-carboxylic acid (3-methylcyclohexyl) ester
C20H26N2O5 (374.18416260000004)
6-(3,5-dimethyl-4-isoxazolyl)-N-[(2-ethoxyphenyl)methyl]-4-quinazolinamine
1-[(E)-3-[4-[2-(dimethylamino)ethoxy]-3,5-dimethoxyphenyl]prop-2-enoyl]-2,3-dihydropyridin-6-one
C20H26N2O5 (374.18416260000004)
N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]-2-phenylacetamide
C20H26N2O5 (374.18416260000004)
(2S,3R,4S)-1-[2-(dimethylamino)-1-oxoethyl]-4-(hydroxymethyl)-3-[4-[2-(3-pyridinyl)ethynyl]phenyl]-2-azetidinecarbonitrile
N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]-2-phenylacetamide
C20H26N2O5 (374.18416260000004)
N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]-2-phenylacetamide
C20H26N2O5 (374.18416260000004)
N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]-2-phenylacetamide
C20H26N2O5 (374.18416260000004)
N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]-2-phenylacetamide
C20H26N2O5 (374.18416260000004)
N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]-2-phenylacetamide
C20H26N2O5 (374.18416260000004)
N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]-2-phenylacetamide
C20H26N2O5 (374.18416260000004)
N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-(4-morpholinyl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]-2-phenylacetamide
C20H26N2O5 (374.18416260000004)
4-({[(1S,3S,4R)-3-(dimethylcarbamoyl)bicyclo[2.2.2]oct-1-yl]carbamoyloxy}methyl)benzoic acid
C20H26N2O5 (374.18416260000004)
10,13-Dimethyl-7-sulfanylspiro[2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17,5-oxolane]-2,3-dione
CCK antagonist 1
CCK antagonist 1 (compound 3d) is a CCK antagonist with IC50s of 1.1 μM and 4 μM for CCK1 and CCK2, respectively. CCK antagonist 1 can be used for research of cancer and mental disease[1].
1-[7-hydroxy-2,2-dimethyl-8-(3-methylbut-2-en-1-yl)chromen-6-yl]-3-phenylprop-2-en-1-one
2-[(dodecyloxy)carbonyl]-4-hydroxy-5-oxooxolane-3-carboperoxoic acid
[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-{[(2s,3e)-5-hydroxy-5-methyl-2-(prop-1-en-2-yl)hex-3-en-1-yl]oxy}oxan-2-yl]methyl acetate
(1r,2r)-p-menth-4(5)-ene-1,2-diol1-o-β-d-(2-o-acetyl)glucopyranoside
{"Ingredient_id": "HBIN003070","Ingredient_name": "(1r,2r)-p-menth-4(5)-ene-1,2-diol1-o-\u03b2-d-(2-o-acetyl)glucopyranoside","Alias": "NA","Ingredient_formula": "C18H30O8","Ingredient_Smile": "CC(C)C1=CCC(C(C1)O)(C)OC2C(C(C(C(O2)CO)O)O)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "13738","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(1r,2r)-p-menth-4(5)-ene-1,2-diol1-o-β-d-(6-o-acetyl)glucopyranoside
{"Ingredient_id": "HBIN003071","Ingredient_name": "(1r,2r)-p-menth-4(5)-ene-1,2-diol1-o-\u03b2-d-(6-o-acetyl)glucopyranoside","Alias": "NA","Ingredient_formula": "C18H30O8","Ingredient_Smile": "CC(C)C1=CCC(C(C1)O)(C)OC2C(C(C(C(O2)COC(=O)C)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "13739","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
8,8-dimethyl-2-phenyl-10-prenyl-2,3-dihydro-8h-pyrano[3,2-g]chroman-4-one
{"Ingredient_id": "HBIN013576","Ingredient_name": "8,8-dimethyl-2-phenyl-10-prenyl-2,3-dihydro-8h-pyrano[3,2-g]chroman-4-one","Alias": "NA","Ingredient_formula": "C25H26O3","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6396","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(2s)-8,8-dimethyl-6-(3-methylbut-2-en-1-yl)-2-phenyl-2h,3h-pyrano[2,3-f]chromen-4-one
{3,4,5-trihydroxy-6-[(4-hydroxy-3,7-dimethylocta-2,6-dien-1-yl)oxy]oxan-2-yl}methyl acetate
n-(2-{6-methoxy-3,11,21-triazapentacyclo[12.7.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(14),4,6,8,10,15,17,19-octaen-2-yl}ethyl)carboximidic acid
1-[5-hydroxy-2-methyl-2-(4-methylpent-3-en-1-yl)chromen-6-yl]-3-phenylprop-2-en-1-one
(1e,4s,5r,7r,10r,12e)-1-chloro-12-(chloromethylidene)-5,7-dimethylheptadec-1-en-16-yne-4,10-diol
C20H32Cl2O2 (374.17792319999995)
(2e)-1-[(2s)-5-hydroxy-2-methyl-2-(4-methylpent-3-en-1-yl)chromen-6-yl]-3-phenylprop-2-en-1-one
3-carbonoperoxoyl-4-(1-hydroxydodecyl)-5-oxooxolane-2-carboxylic acid
2-({7-[4-(dimethylamino)phenyl]-1-hydroxy-4,6-dimethyl-7-oxohepta-2,4-dien-1-ylidene}amino)-3-hydroxypropanoic acid
C20H26N2O5 (374.18416260000004)
(2e)-1-[(2r)-5-hydroxy-2-methyl-2-(4-methylpent-3-en-1-yl)chromen-6-yl]-3-phenylprop-2-en-1-one
(2s,3r,4r)-2-[(dodecyloxy)carbonyl]-4-hydroxy-5-oxooxolane-3-carboperoxoic acid
(2s,3r,4s,5s,6r)-2-{[(1r,3as,4s,6s,8ar)-1,6-dihydroxy-1,4-dimethyl-2,3,3a,5,6,8a-hexahydroazulen-4-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
[2-(pent-2-en-1-yl)-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclopentyl]acetic acid
2-{[(2e,4e,6r)-7-[4-(dimethylamino)phenyl]-1-hydroxy-4,6-dimethyl-7-oxohepta-2,4-dien-1-ylidene]amino}-3-hydroxypropanoic acid
C20H26N2O5 (374.18416260000004)
(2r,3r,4s)-3-carbonoperoxoyl-4-dodecyl-4-hydroxy-5-oxooxolane-2-carboxylic acid
2-[(3,4-dihydroxy-1,4-dimethyl-2,3,3a,5,6,8a-hexahydroazulen-1-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
3-carbonoperoxoyl-4-dodecyl-4-hydroxy-5-oxooxolane-2-carboxylic acid
(2r,3r,4s,5s,6r)-4,5-dihydroxy-2-{[(6e)-8-hydroxy-7-methyl-3-methylideneoct-6-en-1-yl]oxy}-6-(hydroxymethyl)oxan-3-yl acetate
6-(3-hydroxy-4-methylpentan-2-yl)-3-methyl-4-{[(3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-5,6-dihydropyran-2-one
2-[(1,6-dihydroxy-1,4-dimethyl-2,3,3a,5,6,8a-hexahydroazulen-4-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
(2s,3r,4s,5r,6r)-2-{[(1r,3as,4s,6s,8as)-1,6-dihydroxy-1,4-dimethyl-2,3,3a,5,6,8a-hexahydroazulen-4-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2s,3r,4s,5s,6r)-2-{[(1s,3s,3as,4r,8as)-3,4-dihydroxy-1,4-dimethyl-2,3,3a,5,6,8a-hexahydroazulen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
6-(3-hydroxy-4-methylpentan-2-yl)-3-methyl-4-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-5,6-dihydropyran-2-one
4,5-dihydroxy-2-[(8-hydroxy-7-methyl-3-methylideneoct-6-en-1-yl)oxy]-6-(hydroxymethyl)oxan-3-yl acetate
[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-{[(2e,4s)-4-hydroxy-3,7-dimethylocta-2,6-dien-1-yl]oxy}oxan-2-yl]methyl acetate
(3,4,5-trihydroxy-6-{[5-hydroxy-5-methyl-2-(prop-1-en-2-yl)hex-3-en-1-yl]oxy}oxan-2-yl)methyl acetate
n-{2-[(2r)-6-methoxy-3,11,21-triazapentacyclo[12.7.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(14),4,6,8,10,15,17,19-octaen-2-yl]ethyl}carboximidic acid
[(1r,2r,3r)-2-[(2z)-pent-2-en-1-yl]-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclopentyl]acetic acid
(1's,3s,4's,7's,8's,9's,12's)-7'-ethyl-7',12'-dihydroxy-1-methoxy-11'-oxa-5'-azaspiro[indole-3,2'-tricyclo[6.3.1.0⁴,⁹]dodecan]-2-one
C20H26N2O5 (374.18416260000004)